BSD Medical nets Erlangen order
Hyperthermic oncology therapy treatment system developer BSD Medical of Salt Lake City, reported that the department of radiation oncology of the Erlangen University Medical School in Erlangen, Germany, has placed an order for its BSD 2000/3D/MR. The device is a regionalized hyperthermia system with integrated MRI capabilities, BSD said.
The MRI capabilities allow the imaging of treatments in progress, by color-grading the images to reflect temperature changes in the cancerous region during deep hyperthermia therapy, the company said.
The BSD-2000/3D/MR was developed with the collaborative effort of Siemens Medical Solutions, although BSD Medical holds all commercial rights to the hyperthermia system and the license to a U.S. National Institutes of Health (NIH) patent related to these techniques.
The Erlangen system will mark the third BSD-2000 system used with integrated MRI capability adopted by educational institutions in Germany, following the BSD-2000/3D/MR systems installed at the Grosshadern University Medical School and the Berlin Charite University Medical School, according to the firm.
The MRI capabilities allow the imaging of treatments in progress, by color-grading the images to reflect temperature changes in the cancerous region during deep hyperthermia therapy, the company said.
The BSD-2000/3D/MR was developed with the collaborative effort of Siemens Medical Solutions, although BSD Medical holds all commercial rights to the hyperthermia system and the license to a U.S. National Institutes of Health (NIH) patent related to these techniques.
The Erlangen system will mark the third BSD-2000 system used with integrated MRI capability adopted by educational institutions in Germany, following the BSD-2000/3D/MR systems installed at the Grosshadern University Medical School and the Berlin Charite University Medical School, according to the firm.